| Bioactivity | Defoslimod (OM 174) is an agonist for TLR4 receptor and acts as an immunomodulator. Defoslimod activates macrophages and dendritic cells, induces cytokines secretion, and exhibits antitumor efficacy in rats[1]. |
| CAS | 171092-39-0 |
| Formula | C52H100N2O20P2 |
| Molar Mass | 1135.30 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Isambert N, et al., Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors. BMC Cancer. 2013 Apr 2;13:172. |
Defoslimod
CAS: 171092-39-0 F: C52H100N2O20P2 W: 1135.30
Defoslimod (OM 174) is an agonist for TLR4 receptor and acts as an immunomodulator. Defoslimod activates macrophages and
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.